A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013.
Saved in:
| Title: | A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013. |
|---|---|
| Authors: | Ademuyiwa FO; Washington University School of Medicine, St Louis, MO, 63110, USA. bisiademuyiwa@wustl.edu., Gao F; Washington University School of Medicine, St Louis, MO, 63110, USA., Street CR; Washington University School of Medicine, St Louis, MO, 63110, USA., Chen I; Washington University School of Medicine, St Louis, MO, 63110, USA., Northfelt DW; Mayo Clinic, Phoenix, AZ, 85054, USA., Wesolowski R; Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210, USA., Arora M; UC Davis Comprehensive Cancer Center, Sacramento, CA, 95817, USA., Brufsky A; University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA., Dees EC; University of North Carolina School of Medicine, Chapel Hill, NC, 27514, USA., Santa-Maria CA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, 21287, USA., Connolly RM; University College Cork, Cork, Ireland., Force J; Duke University School of Medicine, Durham, NC, 27710, USA., Moreno-Aspitia A; Mayo Clinic, Jacksonville, FL, 32224, USA., Herndon JM; Washington University School of Medicine, St Louis, MO, 63110, USA., Carmody M; Washington University School of Medicine, St Louis, MO, 63110, USA., Davies SR; Washington University School of Medicine, St Louis, MO, 63110, USA., Larson S; Washington University School of Medicine, St Louis, MO, 63110, USA., Pfaff KL; Cancer Immune Monitoring and Analysis Center, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Jones SM; Cancer Immune Monitoring and Analysis Center, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Weirather JL; Cancer Immune Monitoring and Analysis Center, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Giobbie-Hurder A; Cancer Immune Monitoring and Analysis Center, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Rodig SJ; Cancer Immune Monitoring and Analysis Center, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Liu Z; Washington University School of Medicine, St Louis, MO, 63110, USA., Hagemann IS; Washington University School of Medicine, St Louis, MO, 63110, USA., Sharon E; National Cancer Institute, Bethesda, MD, 20892, USA., Gillanders WE; Washington University School of Medicine, St Louis, MO, 63110, USA. gillandersw@wustl.edu. |
| Source: | NPJ breast cancer [NPJ Breast Cancer] 2022 Dec 30; Vol. 8 (1), pp. 134. Date of Electronic Publication: 2022 Dec 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2374-4677 |
|---|---|
| DOI: | 10.1038/s41523-022-00500-3 |
